Navigation Links
Valencia College verwendet hochmoderne Simbionix-Simulatoren für Ausbildungsprogramm im Bereich kardiovaskulärer Technologie
Date:3/20/2013

CLEVELAND, March 20, 2013 /PRNewswire/ --

Simbionix bietet sogenannte Cardiovascular Technology (CVT)-Programme (dt. Programme für Herz-Kreislauf-Technologie) mit Ausbildungssimulatoren, die den Studierenden virtuell eine lebensechte Lernerfahrung bieten. Das Valencia College in Orlando, Florida, wendet diese Technologie in seinem CVT-Programm am Allied Health Department an.

     (Logo: http://photos.prnewswire.com/prnh/20120502/529202-a)

Die Hochschul-Ausbilder verwenden die Simulatoren von Simbionix, um den Studenten ein lebensecht simuliertes Umfeld für endovaskuläre und periphere vaskuläre Eingriffe zu bieten. Die Module des ANGIO Mentor sind für die Bereiche Herz, Herzrhythmusmanagement, Nieren, SFA, Becken und den Bereich unter dem Knie konzipiert.

"Letztlich ist die Verwendung von Simulation in den gesundheitswissenschaftlichen Ausbildungsprogrammen bei Valencia für die Ausbildung der Studierenden von höchster Bedeutung", erklärt Penny Conners , Dekanin für Gesundheitsberufe am Valencia College . "In unserem CVT-Programm lernen die Studierenden anhand des Simbionix-Simulators die exakten Vorgänge, die sie später im Krankenhaus durchführen werden. So hilft die Simulation den Studierenden, die bestmögliche Versorgung in ihrem Bereich zu erlernen und die Sicherheit der Patienten dabei stets an erster Stelle zu positionieren."

Der ANGIO Mentor ermöglicht Erfahrungen mit grundlegenden/fortgeschrittenen Fähigkeiten mit Führungsdrähten und Kathetern und bei endovaskulären Eingriffen. Außerdem kann Team-Erfahrung im Katheterlabor gesammelt werden. Weiterhin wird erlernt, wie der C-Arm, der Patiententisch und der
'/>"/>

SOURCE Simbionix Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valencia College Utilizes Sophisticated Simbonix Simulators in Their Cardiovascular Technology (CVT) Training Program
2. Two of Psyche Systems Customers to Speak at 2013 Executive War College
3. Gentris Integrated Biorepository Receives Accreditation From The College of American Pathologists
4. Guardsman Scientific Lead IP Council to Present at the American College of Cardiology National Meeting
5. Martha Connolly Inducted into American Institute for Medical and Biological Engineering College of Fellows
6. Elsevier and the American College of Cardiology Announce the Launch of a New Journal JACC: Heart Failure
7. Boston Scientific Schedule Of Major Presentations At The American College Of Cardiology 2013
8. Medical Sales College Signs Training Agreement With TASSMA, Inc.
9. Emerald Logic announces collaboration with Kings College London on quantitative biomarker discovery
10. A Forever Recovery Battle Creek, MI: Increasing Recreational Drug Use in Colleges Creates Risk for Addictions
11. New Pre-Clinical and Clinical Data on GeNO LLCs Nitric Oxide Delivery Systems to Be Presented at 2013 American College of Cardiology and American Thoracic Society Medical Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  XBiotech announced ... study being conducted in the US for its ... Human™ monoclonal antibody therapy, is being evaluated in ... complicated with cachexia. The primary endpoint of the ... treated patients to a control population provided only ...
(Date:9/2/2014)... , Sept. 2, 2014 Reportlinker.com announces ... in its catalogue: Acute Heart Failure ... http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html Acute Heart ... Summary GlobalData,s clinical trial report, "Acute ... provides data on the Acute Heart Failure clinical ...
(Date:9/2/2014)... 2014 According to a ... "Latin America Home Healthcare Market (By Device Types: ... Mobility Assist Devices and Medical Supplies; By Services: ... and Unskilled Home Healthcare Services) - Industry Analysis, ... 2020" the Latin American Home Healthcare market was ...
Breaking Medicine Technology:XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6
... 27 Tengion, Inc. (Nasdaq: TNGN ), ... its first Analyst and Investor Meeting which was held ... and discussions of milestones and key data for the ... archive of the event and presentation materials will be ...
... DEL REY, Calif., Oct. 27 Prostate Oncology Specialists, ... sites in the nation to treat advanced prostate cancer ... therapeutic class known as autologous cellular immunotherapies.  PROVENGE was ... for the treatment of men with asymptomatic or minimally ...
Cached Medicine Technology:Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 2Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 3Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 4Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 5Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 2Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 3Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 4
(Date:9/2/2014)... Angeles, CA (PRWEB) September 02, 2014 ... article on its website titled “Why You Should Wash ... than 80 percent of the global population breathes air ... and particles of pollution lodge in the skin’s pores ... body’s natural barrier to free radicals that may cause ...
(Date:9/2/2014)... groundwork for their own spread throughout the body by ... signals, according to a new report by Johns Hopkins ... Nature Communications , the researchers describe animal and ... molecules released by breast cancer cells. These molecules cause ... nodes to produce proteins called CCL5 and VEGF. CCL5 ...
(Date:9/2/2014)... By Kathleen Doheny ... -- The U.S. obesity epidemic is a driving force behind ... new study. Researchers looked at data from five national ... the increase in diabetes over time could be explained by ... in U.S. adults. The investigators found that the prevalence ...
(Date:9/2/2014)... News) -- A leading group of oncologists has released ... of advanced breast cancer. HER2-negative breast tumors ... the HER2 protein, the American Society of Clinical Oncology ... Almost 80 percent of women with advanced breast cancer ... this guideline, our aim is to improve both the ...
(Date:9/2/2014)... research on sleep apnea, tonsillectomies, hearing loss, head ... be presented in Orlando, FL, September 21-24, at ... the American Academy of OtolaryngologyHead and Neck Surgery ... nose, throat, head and neck physicians in the ... presented were released today, and are available online ...
Breaking Medicine News(10 mins):Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 3Health News:New Guidelines for Treating Form of Advanced Breast Cancer 2
... women with a common thyroid problem may have a ... ,Studies in the past have shown that one of ... Although animal studies found mammary gland cells responded to ... in the relationship between thyroid hormone and breast cancer. ...
... allergen found in the air in many inner-city homes ... in children say researchers. ,According to researchers children ... allergy-causing substance found in mouse urine that is circulating ... developing allergic sensitivity to mice, just as it does ...
... live their lives by their sports drinks and energy drinks ... athletic achievements. //According to a study published in the January ... dental enamel is caused by bottled lemonade, sports drinks and ... enamel by these drinks are as much as 11 times ...
... there are actually scientific reasons why children may be ... strong // sweet tooth. Researchers found variation in a ... and adults. Age and culture also contribute to taste ... the study researchers compared taste sensitivity and food-related behaviors ...
... to evaluate the effect of diseases on contact with children ... were less likely to get the kind of affection other ... HIV-positive parents report avoided certain types of physical contact with ... to their children or pick up infections from the kids ...
... gum disease are more likely to suffer from atherosclerosis, or ... attack // or stroke shows latest research . ... mouths of 657 people who had no history of heart ... used to identify atherosclerosis, was also measured. People with a ...
Cached Medicine News:
... revolutionary new digital imaging technology ... chip right at the distal ... a thing of the past. ... at the site of surgery. ...
... Light Source is similar to ... of dual lamps and a ... source is ideal for all ... added feature of a backup, ...
... MODULARIS Litho from Siemens Medical Solutions is ... management of stone disease. Urodiagnostics, endourology, lithotripsy, ... may all be part of a urologists ... the complete solution that supports the various ...
... not only one of the most modern lithotripters ... Apart from being designed for the treatment of ... tract, the MODULITH SLX can also be employed ... is equally suitable for the treatment of gallstones ...
Medicine Products: